Tandem Diabetes Care, Inc. announced a partnership with Juvenile Diabetes Research Foundation International Inc. (JDRF) to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin. JDRF will support Tandem in performance-based milestone funding over the next two years to complete the development, testing, and manufacturing of a novel infusion pump that can simultaneously deliver two injectable hormonal drug therapies.